Full text is available at the source.
Abstract
Colorectal cancer may benefit from targeting multiple regulated cell death pathways to overcome chemoresistance.
- Epithelial-mesenchymal transition, colorectal cancer stem cells, and apoptosis evasion are associated with chemoresistance in colorectal cancer.
- Natural and synthetic compounds can potentially modulate cell death pathways such as ferroptosis, cuproptosis, paraptosis, and autophagy.
- Key regulatory pathways include Wnt/β-catenin, TGF-β, JAK2/STAT3/GPX4, and p38α, which may influence treatment efficacy.
- Compounds like neferine, ajoene, and curcumin analogs, along with drugs like 5-FU and oxaliplatin, are linked to the modulation of EMT and chemoresistance.
- Targeting multiple aspects of EMT, cancer stem cell maintenance, and chemoresistance could represent a new therapeutic approach for colorectal cancer.
Simplified